Alternatives to Neurosoft Bioelectronics

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Brain-computer interface for restoring communication and mobility for people with paralysis.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing a brain-computer interface for high-bandwidth neural data acquisition and stimulation.

Developing a cortical visual prosthesis to restore functional vision for the severely blind.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing lightweight bionic technology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.